Get started
Hims & Hers Health, Inc. Class AHims & Hers Health, Inc. Class AHims & Hers Health, Inc. Class A

Hims & Hers Health, Inc. Class A

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsBondsETFs

A2QMYY trade ideas

HIMS 1D: time to heal the trend?On the daily chart, Hims & Hers Health is testing a descending trendline, while MA50 and MA200 provide strong support from below. Buyers are clearly in control. The highlighted buy zone sits around $54.40, but the real signal comes only after a confirmed breakout and retest of the trendline. Technically , the targets are set: first stop at $73.23, then $86.64, and if momentum holds, the extension points to $103.69. That would mark a strong continuation of the bullish move. From the fundamental side, the company keeps expanding its product portfolio and growing its presence in telehealth — a sector known for resilience even during market turbulence. The tactical play: wait for the breakout and retest, then ride the bullish wave. Just don’t confuse HIMS with a real doctor - if you ask for a prescription for profits, all you’ll get is a smile.
NYSE:HIMSLong
by TotoshkaTrades
2
HIMS OCT 2025HIMS — Price is holding above the 50–45 support and the rising trendline after repeated mid-range rejections. Supply/distribution remains inside the upper box (gap overhead). Bids show absorption in 50–45; 40 is the last institutional support before the weekly base at 25–20. • Target up: 58–60 (gap fill), stretch 65–70 under major supply. • Target down: 50 → 45 → 40; loss of 40 opens 25–20 weekly support. #HIMS #globaltrade #investment #investing #stockmarket #wealth #realestate #markets #economy #finance #money #forex #trading #price #business #currency #blockchain #crypto #cryptocurrency #airdrop #btc #ethereum #ico #altcoin #cryptonews #Bitcoin #ipo
NYSE:HIMSLong
by TWMMPRO
Will Hims & Hers Health Sustain Its Bullish Growth Trajectory?Current Price: $52.54 Direction: LONG Targets: - T1 = $55.20 - T2 = $58.50 Stop Levels: - S1 = $50.50 - S2 = $49.00 **Wisdom of Professional Traders:** This analysis synthesizes insights from thousands of professional traders and market experts, leveraging collective intelligence to identify high-probability trade setups. The wisdom of crowds principle suggests that aggregated market perspectives from seasoned professionals often outperform individual forecasts. Traders have identified Hims & Hers Health as a high-growth opportunity, emphasizing consistent quarterly performance and strong retail demand for healthcare solutions in a rapidly evolving industry. **Key Insights:** Hims & Hers Health has emerged as a leader in the telehealth market, benefiting from consumer-focused strategies and robust product offerings. Analysts widely credit the company’s success to its ability to address gaps in traditional healthcare with affordable, convenient solutions. Its subscription-based model is seen as sticky, driving recurring revenues that appeal to institutional investors. The company has aggressively expanded its operations in 2025, tapping into new markets and broadening its product range while maintaining tight cost controls. Key metrics, such as its subscriber growth rate and gross margin improvements, indicate that Hims & Hers is not just growing its top-line revenue but also achieving greater operational efficiency. With the healthcare demands of Gen Z and millennials surging, the company is positioned to capitalize on strong secular trends. **Recent Performance:** Hims & Hers Health has shown resilience in recent quarters, beating Wall Street estimates in Q2 2025 with 28% year-over-year revenue growth and record-breaking net subscriber additions. The stock’s current price reflects a healthy consolidation after rallying from $45 earlier this year. Despite broader market volatility, HIMS has stayed firmly bullish due to its strong fundamentals and sector tailwinds. **Expert Analysis:** Experienced market professionals emphasize Hims & Hers Health’s innovative approach in an increasingly competitive telehealth space. Technical analysis highlights the stock’s bullish breakout above the $50 level, which has now turned into strong support. The RSI, currently at 61, indicates room for further upside without overextended momentum. Moving averages are trending upwards, reflecting bullish sentiment, while trading volumes remain elevated, confirming institutional interest in the equity. Experts also point to management’s proactive initiatives, such as international expansion and partnerships with key retailers, as catalysts for sustained growth. Hims & Hers' ability to balance aggressive growth strategies without compromising profitability has made it a standout performer. Traders are closely watching its upcoming Q3 earnings report as the next potential inflection point for price momentum. **News Impact:** Recent news regarding Hims & Hers Health’s partnership with leading pharmacy chains has added additional credibility to its retail strategy, widening its consumer base and boosting investor confidence. Furthermore, analysts highlight its successful entry into remote mental health services, which is projected to drive incremental revenue for the upcoming quarters. Positive media coverage on its competitive edge in subscription programs has reinforced the stock’s image as a high-growth play. **Trading Recommendation:** With strong fundamentals, sector leadership, and bullish technical indicators, traders should consider going long on HIMS. The stock’s recent movements suggest a clear upward trajectory, supported by robust demand for its products and services. Buy positions should be initiated with a stop-loss at $50.50 (S1) to manage risks effectively, while targeting $55.20 (T1) and $58.50 (T2) for potential upside gains. Upcoming earnings and operational updates may further fuel investor sentiment and drive momentum into 2025. Do you want to save hours every week? Register for the free weekly update in your language!
NYSE:HIMSLong
by CrowdWisdomTrading
$HIMS growth slowdown ahead- NYSE:HIMS is quite overvalued. There's no moat to a business model. - They got a good branding that's all. There are 10-15 other startups selling the same things under different umbrella. - They even stole NYSE:NVO flagship weight loss drugs. These cheap alternatives will risk lives of people and will open plethora of lawsuits. - Growth is slowing down to low 20s which calls for correction in the multiple. - Anyone paying more than 20x will likely suffer from massive losses within an year timeframe. - Fundamentally, Year | 2025 | 2026 | 2027 | 2028 EPS | 0.57 | 0.79 | 1.05 | 1.40 EPS% | 5.76% | 38.31% | 32.59% | 33.25% Giving benefit of doubt and being generous, 30x multiple as a base case. Fair stock value: Year | 2025 | 2026 | 2027 | 2028 Price | $17 | $23 | $31 | $42 - We should visit the $23-26 range somewhere in 2026
NYSE:HIMSShort
by bigbull037
$HIMS weekend analysis - 21st September, 2025Last week’s news-driven dip to the 48–49 range turned into a solid buying opportunity - the quick recovery shows it was more noise than substance. With the strong bounce, price looks set to retest the key 62.3 - 64.9 resistance zone, which could be the target for this week. If we get a daily close above that zone and it flips into support, there’s a real shot at new 52-week highs in the short term. On the downside, a close below 50.4 (volume shelf) would break this setup and call for a re-check.
NYSE:HIMSLong
by zaidriaz992
1
Hims long into supplyHims has decided to push the supply as we previously mentioned. We note a breakout of the OBV, which I have been tracking (momentum). As I previously stated, I was looking for a push to 60 again. Volatility has reset, and shorts are being squeezed. I would like to think that 51-ish is the new range, but he likes to surprise in both directions. I believe we push 65$ here in the short term. Volume is rising on the weekly. My plan: I sold shares into this pump in my IRA to focus more on large caps there (AMD). I did swing some new shares on this move. Sell calls into the top of supply at 63, put sells should be safe, as well as 6 mo + calls
NYSE:HIMSLong
by Apollo_21mil
Hims & Hers Health, Inc. NYSE- (W)-institutional participationPrice has bounced back from recent pullbacks and is now approaching a key resistance zone near $65.85 (previous highs marked in red). Above $65.85, the next Fibonacci extensions point toward $76.15, $86.04, and $95.94 as potential upside targets. Volume The recent green candles are supported by higher-than-average volume, suggesting strong buying interest. Volume spikes during upward moves often confirm institutional participation. The blue line (volume MA) shows that current activity is above average, reinforcing bullish momentum. Support Levels: $46.45 (short-term). Risk: Failure to break $65.85 could trigger another pullback toward support. Bias Bullish — Structure indicates strength. If price sustains above $56–57, the next leg towards $65.85 – $95.94 is likely. ⚠️ Disclaimer: This chart is for educational purposes only. Regulatory Note: We are an independent development team. Our services are not registered or licensed by any regulatory body in India, the U.S., the U.K., or any global financial authority. Please consult a licensed advisor before making trading decisions.
NYSE:HIMSLong
by Dr_Bean
Don't Hold a Bag, HIMSHello I am the Cafe Trader. Today we’re looking again at the hyped HIMS (Hims & Hers Health). This is a wide range, make sure you get good pricing if you add to the long term. Price is currently sitting right above Strong Buyers These buyers are holding, and the shorts may be exhausting having to cover soon. So I have provided a trade idea to finesse this action. . Green Scenario If buyers continue to hold this demand, I expect a push into the Bottom of Supply around 52. That’s the first stop, and a strong reaction there would tell us whether Sellers are really active, or buyers are ready to push into the higher supply zones. The more aggressive case would be continuation all the way into the Extreme Supply area closer to 65–68. Long Term Aggressive: 44–45 (Strong Buyers, current zone) Extreme Value: 26 (Extreme Demand — if buyers completely lose control, this is where I’d expect institutions to step in). For now, HIMS looks bullish off this demand, but keep in mind that if we do lose this box and rotate down, it could open up a move all the way into the 26 range. so If we close end of week below the strong buyers, don't be afraid to trim your position, and reload at. a better price. Don't be a bag holder. Happy Trading, @thecafetrader
NYSE:HIMSLong
by thecafetrader
8
Hims breakoutHims looks to break out deeper into the weekly supply zone on this push. With massive short interest and retail hype, it will likely at least have a lot of attention. OBV wedge looks for a breakout to the upside, and we just saw a blue flash on BBWP (volatility). I would not be looking for profits until around $ 60$ here, with the swing high at $73. My setup: I added shares around 48, and sold covered calls aggressively between the 51-54$ zone for this week because the premiums were so high. I still have a 75,000$ net long share position.
NYSE:HIMSLong
by Apollo_21mil
2
HIMS may be preparing its next push up!This one is getting my attention too. It's among the best performers TTM and was digesting its last year push in the recent quarters but that could soon change if it breaks again that somehow chaotic handle. Nothing is granted in life but I think that all the ingredients are there for it to make it happen. Relevant points at the time of writing: 1. We are at a new Market cycle since June 25. 2. Market direction is UP some 90% 3. Stock fundamentals are good with a strong RS Rating of 94. 4. We are at Base 1 just after a reset. 5. Good volume profile with signs of institutional Accumulation
NYSE:HIMSLong
by AL26
HIMS LONG Swing Entry PlanNYSE:HIMS LONG Swing Entry Plan Entry Zone 1: $46.10 – $46.50 → Open initial position targeting +8% from entry level. Entry Zone 2: $43.00 – $43.20 → If price dips further, average down with a second equal-sized entry. → New target becomes +8% from the average of Entry 1 and Entry 2. AD Zone : $37.80 – $38.50 → If reached, enter with double the initial size to lower the overall cost basis. → Profit target remains +8% from the new average across all three entries. Risk Management: Stop Loss: Risk is capped at 12% below the average entry price (calculated across all executed positions including the Edit Zone). Position Sizing Approach: Entry 1: 1x Entry 2: 1x AD Zone: 2x → Total exposure: 4x → Weighted average determines final TP and SL calculations. ______________________________________ Legal Disclaimer The information provided in this content is intended for educational and informational purposes only and does not constitute financial, investment, or legal advice or recommendations of any kind. The provider of this content assumes no legal or financial responsibility for any investment decisions made based on this information. Users are strongly advised to conduct their own due diligence and consult with licensed financial advisors before making any financial or investment decisions. Sharia Compliance Disclaimer: The provider makes no guarantees that the stocks or financial instruments mentioned herein comply with Islamic (Sharia) principles. It is the user’s responsibility to verify Sharia compliance, and consultation with a qualified Sharia advisor is strongly recommended before making any investment decisions
NYSE:HIMSLong
by DrAlmansoori